Philippe Pibarot, Laval University, Canada

https://umr1087.univ-nantes.fr/medias/photo/dsc-2850_1705393957475-jpg
  • Le 22 January 2024
    Amphi DE
    false false
  • 12h15

Is there a light at the end of the pharmacotherapy tunnel for calcified aortic stenosis?

Is there a light at the end of the pharmacotherapy tunnel for calcified aortic stenosis?


Philippe Pibarot, PhD, Head of Cardiology Research
Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval
Professor, Department of Medicine
Canada Research Chair in Valvular Heart Diseases


 

Biographie


Philippe Pibarot obtained a doctorate in veterinary medicine (DVM) in 1987 at the University Claude Bernard in Lyon, France and a PhD degree in biomedical sciences from the University of Montreal in 1995. He is full professor at the Department of Medicine of Laval University and he holds the Canada Research Chair (Level I) in Valvular Heart Disease (VHD) at the Québec Heart & Lung Institute. He is the head of Cardiology Research at Québec Heart & Lung Institute. The objective of his research program is to develop and validate novel patient-oriented approaches to improve the diagnosis, prevention, and treatment of VHD. He is currently the principal investigator of several multicenter studies and trials. He is director of the Echocardiography Core Laboratory at the Québec Heart & Lung Institute.
He authored over 800 publications and has been the recipient of numerous awards including the Annual Achievement Award of the Canadian Society of Echocardiography, the Research Achievement Award of the Canadian Cardiovascular Society, and the Canadian Society Distinguished Lecturer Award. He is among the top 1% most influential scientists in the field of Medicine according to the Clarivate Analytics - Web of Sciences Highly Cited Researchers from 2018 to 2023.
Mis à jour le 18 January 2024.
https://umr1087.univ-nantes.fr/home/events/philippe-pibarot-laval-university-canada